Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison

Background We recently demonstrated in a randomized, double-blind, placebo-controlled trial that intramyocardial bone marrow cell (BMC) injection is associated with improvements in myocardial perfusion and anginal symptoms in chronic myocardial ischemia patients. In the present study the results of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2012-11, Vol.164 (5), p.771-778
Hauptverfasser:	Rodrigo, Sander F., MD, van Ramshorst, Jan, MD, Beeres, Saskia L., MD, PhD, Al Younis, Imad, MD, Dibbets-Schneider, Petra, BSc, de Roos, Albert, MD, PhD, Fibbe, Willem E., MD, PhD, Zwaginga, Jaap J., MD, PhD, Schalij, Martin J., MD, PhD, Bax, Jeroen J., MD, PhD, Atsma, Douwe E., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angina Pectoris - prevention & control Biological and medical sciences Bone marrow Bone Marrow Cells Cardiology Cardiology. Vascular system Cardiovascular Chronic Disease Coronary Circulation Coronary heart disease Coronary vessels Cross-Over Studies Female Heart Heart attacks Heart Function Tests Humans Injections Leukocytes, Mononuclear Magnetic Resonance Imaging Male Medical sciences Middle Aged Myocardial Ischemia - diagnosis Myocardial Ischemia - physiopathology Myocardial Ischemia - therapy Myocarditis. Cardiomyopathies Myocardium NMR Nuclear magnetic resonance Quality of Life Research Design Severity of Illness Index Tomography, Emission-Computed, Single-Photon Treatment Outcome Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!